202 related articles for article (PubMed ID: 26405784)
21. The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.
Shiferaw N; Salvador-Davila G; Kassahun K; Brooks MI; Weldegebreal T; Tilahun Y; Zerihun H; Nigatu T; Lulu K; Ahmed I; Blumenthal PD; Asnake M
Glob Health Sci Pract; 2016 Mar; 4(1):87-98. PubMed ID: 27016546
[TBL] [Abstract][Full Text] [Related]
22. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.
Ramogola-Masire D; de Klerk R; Monare B; Ratshaa B; Friedman HM; Zetola NM
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):308-13. PubMed ID: 22134146
[TBL] [Abstract][Full Text] [Related]
24. Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study.
Adjorlolo-Johnson G; Unger ER; Boni-Ouattara E; Touré-Coulibaly K; Maurice C; Vernon SD; Sissoko M; Greenberg AE; Wiktor SZ; Chorba TL
BMC Infect Dis; 2010 Aug; 10():242. PubMed ID: 20716343
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
26. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
27. Cervical screening in Africa: discordant diagnosis in a double independent reading. DYSCER-CI Group.
La Ruche G; Mensah-Ado I; Bergeron C; Welffens-Ekra C; Dabis F
J Clin Epidemiol; 1999 Oct; 52(10):953-8. PubMed ID: 10513758
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
Forhan SE; Godfrey CC; Watts DH; Langley CL
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
[TBL] [Abstract][Full Text] [Related]
29. Willingness to use HIV self-test kits and willingness to pay among urban antenatal clients in Cote d'Ivoire and Tanzania: a cross-sectional study.
Ashburn K; Antelman G; N'Goran MK; Jahanpour O; Yemaneberhan A; N'Guessan Kouakou B; Kazemi E; Duffy M; Adama P; Kajoka D; Coombs A; Tayag J; Sullivan D; Vrazo A
Trop Med Int Health; 2020 Sep; 25(9):1155-1165. PubMed ID: 32609932
[TBL] [Abstract][Full Text] [Related]
30. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
31. Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure.
Simen-Kapeu A; La Ruche G; Kataja V; Yliskoski M; Bergeron C; Horo A; Syrjänen K; Saarikoski S; Lehtinen M; Dabis F; Sasco AJ
Cancer Causes Control; 2009 Mar; 20(2):163-70. PubMed ID: 18814048
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania.
Kahesa C; Kjaer SK; Ngoma T; Mwaiselage J; Dartell M; Iftner T; Rasch V
BMC Public Health; 2012 Dec; 12():1055. PubMed ID: 23216752
[TBL] [Abstract][Full Text] [Related]
33. The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.
Abouya L; Coulibaly IM; Wiktor SZ; Coulibaly D; N'kragbo M; N'gbo A; Zahui H; Touré K; Jacquemin K; San-Koffi M; Ackah A; Sassan-Morokro M; Maurice C; Whitaker JP; De Cock KM; Greenberg AE
AIDS; 1998 Mar; 12(5):505-12. PubMed ID: 9543449
[TBL] [Abstract][Full Text] [Related]
34. Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.
Ginindza TG; Almonte M; Dlamini X; Sartorius B
Afr J Prim Health Care Fam Med; 2018 Oct; 10(1):e1-e7. PubMed ID: 30456977
[TBL] [Abstract][Full Text] [Related]
35. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital.
Hayumbu V; Hangoma J; Hamooya BM; Malumani M; Masenga SK
Pan Afr Med J; 2021; 40():235. PubMed ID: 35178146
[TBL] [Abstract][Full Text] [Related]
37. HIV counseling and testing: behavior and practices of women of childbearing age in Abidjan, Côte d'Ivoire. DYSCER-CI Group.
Ramon R; La Ruche G; Sylla-Koko F; Boka-Yao A; Bonard D; Coulibaly IM; Welffens-Ekra C; Dabis F
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(5):470-6. PubMed ID: 9562051
[TBL] [Abstract][Full Text] [Related]
38. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
40. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
